Omega Diagnostics Group PLC Revenue and Competitors
Estimated Revenue & Valuation
- Omega Diagnostics Group PLC's estimated annual revenue is currently $42.2M per year.
- Omega Diagnostics Group PLC's estimated revenue per employee is $251,000
Employee Data
- Omega Diagnostics Group PLC has 168 Employees.
- Omega Diagnostics Group PLC grew their employee count by -3% last year.
Omega Diagnostics Group PLC's People
Name | Title | Email/Phone |
---|---|---|
1 | Product Marketing Manager | Reveal Email/Phone |
2 | Validation Supervisor | Reveal Email/Phone |
Omega Diagnostics Group PLC Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $86.6M | 345 | 2% | N/A | N/A |
#2 | $369.5M | 920 | -23% | $974.7M | N/A |
#3 | $1M | 4 | 0% | N/A | N/A |
#4 | $258.8M | 1031 | 18% | N/A | N/A |
#5 | $136M | 542 | 8% | N/A | N/A |
#6 | $19.8M | 79 | -2% | N/A | N/A |
#7 | $51.7M | 206 | 7% | N/A | N/A |
#8 | $40.9M | 163 | 10% | N/A | N/A |
#9 | $85.1M | 339 | 9% | N/A | N/A |
#10 | $40.4M | 161 | 8% | N/A | N/A |
What Is Omega Diagnostics Group PLC?
Our mission is to improve human health and well-being through innovative diagnostic tests and global partnerships. Omega is focused on providing specialist products, primarily in the immunoassay, in-vitro diagnostics (IVD) market within three segments: Allergy, Health & Wellbeing and Global Health.\n\nIn Allergy, Omega Diagnostics is utilising its allergy R&D experience to develop a range of Specific IgE allergy assays which are distributed by our automation partner Immunodiagnostic Systems Limited (IDS).\n\nIn Health & Wellbeing, through Cambridge Nutritional Sciences (CNS), we are empowering individuals to take control of their health by offering a range of food intolerance tests: Food Detective® (point-of-care), ELISA, Food Print® (Microarray) and CNS Lab Service.\n\nIn Global Health, Omega Diagnostics partnered with the Burnet Institute to deliver a worlds first in VISITECT® CD4, a rapid, convenient and affordable test for CD4 in people living with HIV. The test can be used in decentralised locations and is aimed at improving access to essential diagnostics in low- and middle-income countries.
keywords:N/AN/A
Total Funding
168
Number of Employees
$42.2M
Revenue (est)
-3%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Omega Diagnostics Group PLC News
... Abbott Diagnostics, Roche Diagnostics, GenWay Biotech Inc., Correlogic Systems Creative Diagnostics, Omega Diagnostics Group PLC,...
Omega Diagnostics Group PLC said Thursday that it expects to report a 41% increase in revenue for fiscal 2022 after the strong performance...
March 11 (Reuters) - Omega Diagnostics Group Plc (ODX.L) said on Friday its COVID-19 antigen test kit had not been approved by the UK health...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $142.4M | 633 | N/A | N/A |